GAM
IMNM icon

Gotham Asset Management’s Immunome IMNM Stock Holding History

Gotham Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Hold
10,100
– – ﹤0.01% 1670
2025
Q4 		$217K Sell
10,100
-100
-1% -$1.75K ﹤0.01% 1642
2025
Q3 		$119K Hold
10,200
– – ﹤0.01% 1644
2025
Q2 		$94.9K Hold
10,200
– – ﹤0.01% 1618
2025
Q1 		$68.6K Buy
+10,200
New +$97.9K ﹤0.01% 1523

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Gotham Asset Management's IMNM Position: Q1 2026 in Review

Gotham Asset Management held its Immunome (IMNM) position steady in Q1 2026 at 10,100 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Gotham Asset Management first reported a position in IMNM in Q1 2025 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Gotham Asset Management held 10,100 shares of Immunome worth $221K as of Q1 2026.
  • Gotham Asset Management left its Immunome share count unchanged in Q1 2026.
  • Immunome made up ﹤0.01% of Gotham Asset Management's portfolio in Q1 2026, its #1670 holding.
  • Gotham Asset Management first reported a position in Immunome in Q1 2025 and has held it in 5 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.